drugset / Trial / NCT00567606

Prevention of Osteoporosis in Breast Cancer Survivors

NCT00567606

RandomizedParallel-groupOpen-labelPrevention

Summary

The purpose of this study is to test whether strength/weight training exercises enhance the effectiveness of calcium, vitamin D, and risedronate for the prevention and treatment of osteoporosis in postmenopausal breast cancer survivors.

Timeline

Start
2002-04-01
Primary completion
2007-12-01
Completion
2007-12-01

Drugs

EvaluationDrugModalityDoseRoute
Subject Calcium carbonate Other / unclassified 1200 mg
Subject Risedronate Small molecule 35 mg
Subject Vitamin D Other / unclassified 400 iu